ARTICLE | Clinical News
Infectious diseases: Began Phase I testing
April 9, 2001 7:00 AM UTC
InterMune Pharmaceuticals Inc., Palo Alto, Calif. Business: Infectious diseases Product: Actimmune Therapeutic category: Immune modulation Description: Interferon gamma-1b Target: Unknown Indication:...